Glauconix Biosciences Awarded National Science Foundation Phase IIB Small Business Innovation Research Grant
ALBANY, N.Y., March 23, 2021 /PRNewswire/ -- Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology...